Shao-Lee Lin
Executive Officer, Director at Cue Biopharma.
Raised on Cue Biopharma filings
$80M
of $80M offered across 2 Form D filings
- Form D filings
- 2
- Teammates
- 13
- Last filing
- Jul 22, 2026
Company
Biologics that modulate disease-specific T cells
- Investors
- 118
Cue Biopharma filings
| Filed | Security | Sold of offered | Filing |
|---|---|---|---|
| Jul 22, 2026 | Equity | $50M/ $50M | Form D |
| May 14, 2026 | Security to be acquired | $30M/ $30M | Form D |
Works with
Sumita Ray, JDChief Legal & Compliance Officer, Form D signerForm D signerJill BroadfootDirectorMichael MeluzioExecutive OfficerColin SandercockExecutive OfficerDaniel BakerExecutive OfficerFrank MorichDirectorPatrick VerheyenDirectorPeter KienerDirectorPamela D. GarzoneDirectorDaniel CamardoDirectorDominic BorieExecutive OfficerPasha SarrafDirectorViola MeehanDirector
